Kinetically activating nanovaccine mimicking multidimensional immunomodulation of natural infection for broad protection against heterologous viruses in animal models
Nat. Commun., Published: 25 March 2025 | https://doi.org/10.1038/s41467-025-58006-y
Virulence-Free Reconstituted Synthetic Nanopathogen Empowered by Timely-Activating TLR Agonist Promotes Heterologous Cancer Immunotherapy with Depletion of Tumor-Specific Treg Cells
Adv. Funct. Mater., 03 November 2024 | https://doi.org/10.1002/adfm.202411747
Bioconjugated Antibody-Trojan Immune Converter Enhance Cancer Immunotherapy with Minimized Toxicity by Programmed Two-Step Immunomodulation of Myeloid Cells
Adv. Healthc. Mater., May 21 2024, | https://doi.org/10.1002/adhm.202401270
Molecular Masking of Synthetic Immunomodulator Evokes Antitumor Immunity with Reduced Immune Tolerance and Systemic Toxicity by Temporal Activity Recovery and Sustained Stimulation
Adv. Mater., Oct 30 2023, | https://doi.org/10.1002/adma.202309039